Autopsy report · NCT01037959
Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
Cause of deathSlow enrollment
“lack of recruitement”
Life of this trial
- Registered 4 months before it started.
- Ran for about 5 years 7 months before it stopped.
- 291 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Conditions
- Cirrhosis
- Interventions
- Norfloxacin; Placebo
- Participants
- 291
- Sites
- 1
- Countries
- France
Trials that died the same way
- Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients
“Lack of recruitment” - Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
“lacking recruitment” - Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
“inability to recruit” - Expanding Access to Comprehensive Geriatrics Care Via Telehealth
“Inadequate recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.